Profile picture

Doctor Miguel Sobral Domingues

Western Lisbon Hospital Centre, EPE, Lisbon (Portugal)
Membership: EACVI Member
Follow
Biography
Cardiology resident in Hospital de Santa Cruz, Lisboa
Logo ESC

Contributor content

Prognostic value of early ScvO₂ and pCO₂ gap kinetics and normalisation in patients with cardiogenic shock: a new management target?
Presentation
Prognostic value of early ScvO₂ and pCO₂ gap kinetics and normalisation in patients with cardiogenic shock: a new management target?
See more
LA cardiomyopathy in ATTR-CM: the incremental prognostic value of LA strain
Presentation
LA cardiomyopathy in ATTR-CM: the incremental prognostic value of LA strain
See more
Tafamidis to treat patients with transthyretin cardiac amyloidosis (ATTR-CM): real-world data from a tertiary centre
Presentation
Tafamidis to treat patients with transthyretin cardiac amyloidosis (ATTR-CM): real-world data from a tertiary centre
See more
Effect of apolipoprotein B reduction on major adverse cardiovascular events in randomized controlled trials of triglyceride-lowering therapies: systematic review and exploratory meta-regression
Presentation
Effect of apolipoprotein B reduction on major adverse cardiovascular events in randomized controlled trials of triglyceride-lowering therapies: systematic review and exploratory meta-regression
See more
Prognostic value of stress perfusion CMR: a real-world single-center experience in portuguese patients with known coronary artery disease
Presentation
Prognostic value of stress perfusion CMR: a real-world single-center experience in portuguese patients with known coronary artery disease
See more
Prognostic value of stress perfusion CMR in patients without known coronary artery disease: a real-world single-center experience
Presentation
Prognostic value of stress perfusion CMR in patients without known coronary artery disease: a real-world single-center experience
See more
LA cardiomyopathy in ATTR-CM: the incremental prognostic value of LA strain
Presentation
LA cardiomyopathy in ATTR-CM: the incremental prognostic value of LA strain
See more
Tafamidis to treat patients with transthyretin cardiac amyloidosis (ATTR-CM): real-world data from a tertiary centre
Presentation
Tafamidis to treat patients with transthyretin cardiac amyloidosis (ATTR-CM): real-world data from a tertiary centre
See more
Prognostic value of early ScvO2 and pCO2 gap kinetics and normalization in patients with cardiogenic shock: a new management target?
Presentation
Prognostic value of early ScvO2 and pCO2 gap kinetics and normalization in patients with cardiogenic shock: a new management target?
See more
Prognostic value of stress perfusion cardiac magnetic resonance: real-world evidence from a large Portuguese cohort
Presentation
Prognostic value of stress perfusion cardiac magnetic resonance: real-world evidence from a large Portuguese cohort
See more

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources